My guest is Lisa Aquillano, a Clinical Pharmacy Specialist in Multiple Sclerosis at Emory University Hospital in Atlanta, Georgia. And we're talking about specific steps that you can take to overcome the obstacles standing in the way of gaining access to your MS disease-modifying therapy.
MicroRNA Resolves Mouse Model of MS 5:39
FDA Approves 3 Generics for Gilenya 8:06
Depressed MS Patients Suffer More Serious Physical Disability Earlier 9:39
Google Cracks Down on Stem Cell Clinic Ads 12:25
My Interview with Lisa Aquillano 14:48
Share This Episode 32:19
How to Subscribe to RealTalk MS, Download the RealTalk MS App, and Listen with Alexa 32:43
SHARE THIS EPISODE OF REALTALK MS
Just copy this link & paste it into your text or email: http://realtalkms.com/119
ADD YOUR VOICE TO THE CONVERSATION
I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes.
Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!
Phone: (310) 526-2283
RealTalk MS Episode 119
Hosted By: Jon Strum
Guests: Lisa Aquillano, PharmD, BCPS, MSCS
Tags: MS, MultipleSclerosis, MSResearch, MSSociety, CanDoMS, Gilenya, Depression, Stemcells, RealTalkMS